Hypha Discovery Ltd
↗Abingdon, United Kingdom
Hypha Discovery is a specialist Contract Research Organization (CRO) that provides advanced solutions for the synthesis, purification, and identification of drug and agrochemical metabolites. Founded in 2004, the company has established itself as a global leader in metabolite provision, supporting over 120 companies worldwide, including many of the top pharmaceutical and agrochemical firms.
The company utilizes a unique 'One-Stop Metabolite Shop' approach, combining biological and chemical techniques such as microbial biotransformation, recombinant enzymes (PolyCYPs® and PolyUGTs), and late-stage chemical synthesis. Hypha is particularly recognized for its expertise in solving complex structural elucidation problems using high-field cryoprobe NMR spectroscopy, enabling the definitive identification of metabolites even from microgram quantities.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Metabolite Synthesis and Identification CRO
SIZE & FINANCIALS
Employees:1-50
Revenue:$5M-$10M
Founded:2004
Ownership:private
Status:operating
FUNDING
Stage:Angel
Total Raised:$1.5M
Investors:Innovate UK, University of Westminster Endowment, Santhosh George
PIPELINE
Stage:Discovery
Lead Drug Stage:Not applicable (Service Provider)
Modalities:Small molecule, Metabolites, Natural products, Degraders (PROTACs)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Cypex Limited: Partnership to scale-up and purify metabolites made by Cypex enzymes (Bactosomes), Selcia (Eurofins): Collaboration for radiolabelled ([14C], [3H]) metabolite synthesis, BioBridge K.K.: Exclusive distributor and representative in the Japanese market, RILD (Shanghai): Exclusive distributor of PolyCYPs in China, Galchimia: Joint synthesis of agrochemical metabolites
COMPETITION
Position:Niche Player
Competitors:Pharmaron, Charles River Laboratories, Sekisui Medical, XenoBiotic Laboratories (XBL), Admescope
LEADERSHIP
Key Executives:
Liam Evans - CEO
Jonathan Steele - CSO
Scientific Founders:Liam Evans, Jonathan Steele
Board Members:Professor Henry Joseph Beker
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hypha Discovery Ltd. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.